WINNIPEG, MANITOBA--(Marketwire - July 07, 2008) - Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development of products that prevent and remove microbial biofilms, is pleased to announce that the creation of the Master Cell Bank for manufacturing DispersinB™ has successfully been completed. The Master Cell Bank provides a pure cell culture for manufacturing clinical grade DispersinB™ by fermentation in a cGMP facility.
